Quantitative Cancer Risk Analysis of BHA Based on Integration of Pathological and Biological/Biochemical Information

Abe S. , and Sasaki M. 1977. Chromosome aberrations and sister chromatid exchanges in Chinese hamster cells exposed to various chemicals. J. Natl. Cancer Inst. 58: 1635–1641.

Altmann H.J. , Wiester P.W. , Matthiaschk G. , Grunow W. , and van der Heuden C.A. 1985. Induction of early lesions in the forestomach of rats by 3-tert-butyl-4-hydroxyanisole (BHA). Food Chem. Toxicol. 23: 723–731.

Berridge J.C. , Kent J. , and Norcott K.M. 1984. High-prformance liquid chromatographic separation of the isomers of butylated hydroxyanisole. J. Chromatogr. 285: 389–391.

Clayson D.B. , Iverson F. , Nera E. , Lok E. , Rogers C. , and Rodrigues C. 1986. Histopathological and radioautographical studies on the forestomach of F344 rats treated with butylated hydroxyanisole and related chemicals. Food Chem. Toxicol. 24: 1171–1182.

Cummings S.W. , Ansari G.A.S. , Guengerich F.P. , Crouch L.S. , and Prough R.A. 1985. Metabolism of 3-BHA by microsomal fractions and isolated rat hepatocytes. Cancer Res. 45: 5617–5624.

Degre R. , and Saheb S.A. 1982. Butylated hydroxyanisole as a possible mutagenic agent. FEMS Microbiol. Lett. 14: 183–186.

deStafney C.M. , Prabhu U.D.G. , Sparnins V.L. , and Wattenberg L.W. 1986. Studies related to the mechanism of 3-BHA-induced neoplasia of the rat forestomach. Food Chem. Toxicol. 24: 1149–1157.

Dugan L. Jr. , Hoffert E. , Blumer G.P. , Dabkiewicz I. , and Krabill H.R. 1951. Antioxidant behavior of the isomers of butylated hydroxyanisole. J. Am. Oil. Chem. Soc. 28: 493–495.

Federal Register II. 1985. Chemical Carcinogenesis: A Review of the Science and its Associated Principle, Office of Science and Technology Policy.

Fukushima S. , Sakata T. , Tagawa Y. , Shibata M.A. , Hirose M. , and Ito N. 1987. Different modifying response of butylated hydroxyanisole, butylated hydroxytoluene, and other antioxidants in N, N-dibutylnitrosamine esophagus and forestomach carcinogenesis of rats. Cancer Res. 47: 2113–2116.

Hayashi Y. , Kurokawa Y. , Maekawa A. , and Takahashi M. 1986. Strategy of long-term animal testing for quantitative evaluation of chemical carcinogenicity. In New Concepts and Developments in Toxicology. ( Chambers P.L. , Gehring P. , and Skai F. ed.) pp 383–391.

Hirose M. , Hagiwara A. , Masui T. , Inoue K. , and Ito N. 1986. Combined effects of butylated hydroxyanisole and other antioxidants in induced of forestomach lesions in rats. Cancer Lett. 30: 169–174.

Hirosoe M. , Asamoto M. , Hagiwara A. , Ito N. , Kaneko H. , Saito K. , Takamatsu Y. , Yoshitake A. , and Miyamoto J. 1987. Metabolism of 2- and 3-tert-butyl-4-hydroxyanisole (2- and 3-BHA) in the rat (II): metabolism in forestomach and covalent binding to tissue macromolecules. Toxicology 45: 13–24.

Hirose M. , Inoue T. , Masuda A. , Tsuda H. , and Ito N. 1987. Effects of simultaneous treatment with various chemicals on BHA-induced development of rat forestomach hyperplasia - complete inhibition by diethylmaletate in a 5-week feeding study. Carcinogenesis 8: 1555–1558.

Hirose M. , Masuda A. , Hasegawa R. , Wada S. , and Ito N. 1990. Regression of butylated hydroxyanisole (BHA)-induced hyperplasia but not dysplasia in the forestomach of hamsters. Carcinogenesis 11: 239–244.

IARC. 1985. Some naturally occurring and synthetic food components, furocoumarins and ultraviolet radiation. In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol. 40. IARC, Lyon, France. 126.

Ikeda G.J. , Stewart J.E. , Sapienza P.P. , Peggins J.O. III , Michel T.C. , Olivito V. , Alam H.Z. , and O'Donnell M.W.J. 1986. Effect of subchronic dietary administration of butylated hydroxyanisole on canine stomach and hepatic tissue. Food Chem. Toxicol. 24: 1201–1221.

Imaida K. , Fukushima S. , Shirai T. , Masui T. , Ogiso T. , and Ito N. 1984. Promoting activities of butylated hydroxyanisole, butylated hydroxytoluene and sodium 1-ascorbate on forestomach and urinary bladder carcinogenesis initiated with Methylnitrosourea in F344 male rats. Gann 75: 769–775.

Ishidate M. , and Odashima S. 1977. Chromosome tests with 134 compounds on Chinese hamster cells in vitro - a screening for chemical carcinogens. Mutat. Res. 48.

Ito N. , Hagiwara A. , Shibata M , Ogiso T. , and Fukushima S. 1982. Induction of squamous cell carcinoma in the forestomach of F344 rats treated with butylated hydroxyanisole. Gann 73: 332–334.

Ito N. , Fukushima S. , Hagiwara A. , Shibata M. , and Ogiso T. 1983. Carcinogenicity of butylated hydroxyanisole in F344 rats. J Natl. Cancer Inst. 70: 343–352.

Ito N. , Fukushima S. , Imaida K. , Sakata T. , and Masui T. 1983. Induction of papilloma in the forestomach of hamsters by butylated hydroxyanisole. Gann 74: 459–461.

Ito N. , Hirose M. , Kurata Y. , Ikawa E. , Mera Y. , and Fukushima S. 1984. Induction of forestomach hyperplasia by crude butylated hydroxyanisole, a mixture of 3-tert and 2-tert isomers, in Syrian golden hamsters is due to 3-tert-butylated hydroxyanisole. Gann 75: 471–474.

Ito N. , Fukushima S. , Tamano S. , Hirose M. , and Hagiwara A. 1986. Dose response in Butylated Hydroxyanisole induction of forestomach carcinogenesis in F344 rats. J Natl. Cancer Inst. 77: 1261–1265.

Ito N. , and Hirose M. 1987. The role of antioxidants in chemical carcinogenesis. Jpn. J. Cancer Res. 78: 1011–1026.

Ito N. , and Hirose M. 1989. Antioxidants - Carcinogenic and chemopreventive properties. In Advances in Cancer Research Vol. 53, pp. 247–302, Academic Press Inc.

Iverson F. , Lok E. , Nera E. , Karpinski K. , and Clayson D.B. 1985. A 13-week feeding study of butylated hydroxyanisole: the subsequent regression of the induced lesions in male Fischer 344 rat forestomach epithelium. Toxicology 35: 1–11.

Iverson F. , Truelove J. , Nera E. , Lok E. , Clayson D.B. , and Wong J. 1986. A 12-week study of BHA in the cynomolgus monkey. Food Chem. Toxicol. 24: 1197–1200.

JECFA. 1983. Twenty seventh Report of the Joint FAO/WHO Expert Committee on Food Additives. Technical Report Series 696, WHO, Geneva.

JECFA. 1987. Principles for the Safety Assessment of Food Additives and Contaminants in Food. Environmental Health Criteria 70, WHO, Geneva.

JECFA. 1989. Thirty-third Report of the Joint FAO/WHO Expert Committee on Food Additives. Technical Report Series 776, WHO, Geneva.

Krewski D. , and Murdoch D. 1988. Quantitative factors in carcinogenic risk assessment. In Carcinogen Risk Assessment: New Directions in the Qualitative and Quantitative Aspects ( Hart R.W. , and Hoerger F.D. , ed.) pp. 257–273, Cold Spring Harbor Laboratory.

Masui T. , Hirose M. , Imaida K. , Fukushima S. , Tamano S. , and Ito N. 1986. Sequential changes of the forestomach of F344 rats, Syrian golden hamsters, and B6C3F1 mice treated with butylated hydroxyanisole. Jpn. J. Cancer Res. 77: 1083–1090.

Morimoto K. , Fukuoka M. , Hasegawa R. , Tanaka A. , and Hayashi Y. 1987. DNA damage in urinary bladder epithelium of male F344 rats treated with 2-phenyl-1, 4-benzoquinone, one of the non-conjugated urinary metabolites of sodium o-phenylphenate. Jpn. J. Cancer Res. (Gann), 78: 1027–1030.

Morimoto K. , Sato M. , Fukuoka M. , Hasegawa R. , Takahashi T. , Tsuchiya T. , Tanaka A. , Takahashi A. , and Hayashi Y. 1989. Correlation between the DNA damage in urinary bladder epithelium and the urinary 2-phenyl-1, 4-benzoquinone levels from F344 rats fed sodium o-phenylphenate in the diet. Carcinogenesis 10: 1823–1827.

Morimoto K. , Tsuji K. , Iio T. , Miyata N. , Uchida A. , Osawa R. , Kitsutaka H. , and Takahashi A. 1991. DNA damage in forestomach epithelium from male F344 rats following oral administration of tert-butylquinone, one of the forestomach metabolites of 3-BHA. Carcinogenesis 12: 703–708.

Nera E.A. , Lok E. , Iverson F. , Ormsby E. , Karpinski K.F. , and Clayson D.B. 1984. Short-term pathological and proliferative effects of butylated hydroxyanisole and other phenolic antioxidants in the forestomach of Fischer 344 rats. Toxicology 32: 197–213.

Phillips B.J. , Carroll P.A. , Tee A.C. , and Anderson D. 1989. Microsome mediated clastogenicity of butylated hydroxyanisole (BHA) in cultured Chinese hamster ovary cells: the possible role of reactive oxygen species. Mutat. Res. 214: 105–114.

Rahimtula A. 1983. In vitro metabolism of 3-BHA and its irreversible binding to proteins. Chem. -Biol. Interact. 45: 125–135.

Riley P.A. , and Seal P. 1086. Micro-invasion of epidermis caused by substituted anisoles. Natur 220: 922.

Saito K. , Nakagawa S. , Yoshitake A. , Miyamoto J. , Hirose M. , and Ito N. 1989. DNA-adduct formation in the forestomach of rats treated with 3-tert-butyl-4-hydroxyanisole and its metabolites as assessed by an enzyme ³²P-postlabeling method. Cancer Lett. 48: 189–195.

Sakai A. , and Sato M. 1989. Improvement in carcinogen identification in BALB3T3 cell transformation by application of a 2-stage method. Mutat. Res. 214: 285–296.

Sato H. , Takahashi M. , Furukawa F. , Miyakawa Y. , Hasegawa R. , Toyoda K. , and Hayashi Y. 1987. Initiating potential of 2-(2-furyl)-3-(5-nitro-2-furyl) acrylamide (AF-2), butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and 3, 3', 4', 5, 7-pentahydroxyflavone (quercetin) in two-stage mouse skin carcinogenesis. Cancer Lett. 38: 49–56.

Shirai T. , Fukushima S. , Oshima M. , Masuda A. , and Ito N. 1984. Effects of butylated hydroxyanisole, butylated hydroxytoluene, and NaCl on gastric carcinogenesis initiated with N-methyl-N'-nitro-N-nitrosoguanidine in F344 rats. J. Natl. Cancer Inst. 72: 1189–1198.

Takahashi M. , Furukawa F. , Toyoda K. , Sato H. , Hasegawa R. , and Hayashi Y. 1986. Effects of four antioxidants on N-Methyl-N'-Nitro-N-Nitrosoguanidine initiated gastric tumor development in rats. Cancer Lett. 30: 161–168.

Tatematsu M. , Ogawa K. , Mutai M. , Aoki T. , Hoshiya T. , and Ito N. 1991. Rapid regression of squamous cell hyperplasia and slow regression of basal cell hyperplasia in the forestomach of F344-rats treated with N-methyl-N'-nitro-N-nitrosoguanidine and/or butylated hydroxyanisole. Cancer Research 51: 318–323.

Tobe M. , Furuya T. , Kawasaki Y. , Naito K. , Sekita K. , Matsumoto K. , Ochiai T. , Usui A. , Kokubo T. , Kanno J. , and Hayashi Y. 1986. Six-month toxicity study of butylated hydroxyanisole in beagle dogs. Food

Tsuda H. , Sakata T. , Shirai T. , Kurata Y. , Tamano S. , and Ito N. 1984. Modification of N-methyl-N-nitrosourea initiated carcinogenesis in the rat by subsequent treatment with antioxidants, Phenobarbital and Ethinyl Estradiol. Cancer Lett. 24: 19–27.

Verhagen H. , Furnee C. , Schutte B. , Bosman F.T. , Blijham G.H. , Henderson P.T. , ten Hoor F. , and Kleinjans J.C.S. 1990. Dose-dependent effects of short-term dietary administration of the food additive butylated hydroxyanisole on cell kinetic parameters in rat gastro-intestinal tract. Carcinogenesis 11: 1461–1468.

Williams G.M. 1986. Epigenetic promoting effects of butylated hydroxyanisole. Food Chem. Toxicol. 24: 1163–1166.

Williams G.M. , Tanaka T. , and Maeura Y. 1986. Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene. Carcinogenesis 7: 1043–1050.

Williams G.M. , McQueen C.A. , and Tong C. 1990a. Toxicity studies of butylated hydroxyanisole and butylated hydroxytoluene. I. Genetic and cellular effects. Food Chem. Toxicol. 28: 793–798.

Williams G.M. , Wang C.X. , and Iatropoulos M.J. 1990b. Toxicity studies of butylated hydroxyanisole and butylated hydroxytoluene. II. Chronic feeding studies. Food Chem. Toxicol. 28: 799–806.